靶向白血病干细胞的脂质体纳米免疫疗法通过沉默 B 细胞淋巴瘤 2 逆转免疫逃逸并抑制融合癌蛋白驱动的急性髓系白血病

Leukemic Stem Cell-Targeted Liposomal Nanoimmunotherapy Reverses Immune Evasion and Inhibits Fusion Oncoprotein-Driven Acute Myeloid Leukemia by Silen

从静态风险到动态疾病监测：MRD 与免疫图谱在多发性骨髓瘤中的作用

From static risk to dynamic disease monitoring: the role of MRD and immune profiling in multiple myeloma.

多发性骨髓瘤与重型 SARS-CoV-2 感染的机制互作：间充质干细胞来源细胞外囊泡的治疗前景

Mechanistic Interplay Between Multiple Myeloma and Severe SARS-CoV-2 Infection: Therapeutic Promise of Mesenchymal Stem Cell-Derived Extracellular Ves

iPSC 来源 NK 细胞治疗诱导胶质母细胞瘤持久缓解并通过 B7-H3 靶向三特异性杀伤细胞衔接器克服耐药

iPSC-derived NK cell therapy induces durable responses in glioblastoma and overcomes resistance via a B7-H3-targeted tri-specific killer engager.

FT538 在 77% 的 GSC 细胞系（NK 敏感和中等敏感）中表现出强效的杀肿瘤活性，在敏感模型中具有治愈潜力，并在体内显示出良好的持久性和耐受性。

多发性骨髓瘤感染风险增加的免疫生物标志物

Immune biomarkers of increased infection risk in multiple myeloma.

溶瘤牛疱疹病毒 1 型诱导免疫微环境重塑并增强多发性骨髓瘤的治疗反应

Oncolytic bovine herpesvirus type 1 induces immune microenvironment remodeling and enhances treatment responses in multiple myeloma.

运动动员的淋巴细胞通过 CD16(+) NK 细胞介导的细胞毒性增强多发性骨髓瘤的抗体免疫治疗

Exercise-mobilized lymphocytes enhance antibody-based immunotherapy in multiple myeloma through CD16(+) NK cell-mediated cytotoxicity.

这些发现表明，急性运动可动员一种强效的 NK 细胞亚群，该亚群能增强单克隆抗体对骨髓瘤细胞的疗效。这些发现还凸显了在 MM 中精准把握时机、结合具体情境地整合运动，以优化单克隆抗体疗效的潜力。

复发或转移性头颈部鳞状细胞癌患者治疗前外周淋巴细胞 PD-1 高表达与免疫检查点抑制剂应答不佳相关

High PD-1 expression in pre-treatment peripheral lymphocytes associated with poor immune checkpoint inhibitor response in patients with recurrent or m

单倍体相合异基因细胞移植治疗复发/难治性多发性骨髓瘤

Haploidentical Allogeneic Cell Transplantation in Relapsed/Refractory Multiple Myeloma.

在这一小型、经选择的队列中，采用个体化预处理和清髓方案的半相合异基因 HCT 与经过大量既往治疗的 r/r MM 患者的疾病控制相关。

通过靶向肿瘤微环境中的 CD38 来调控调节性细胞

Regulating the regulators via targeting CD38 in the tumor microenvironment.